The UKNational Screening Committee issued draft guidance in November saying the routine checks should only be offered in very limited circumstances ....
KTX-2001 is being evaluated in the Phase 1 STRIKE-001 clinical trial both as a monotherapy and in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC).
NEW YORK — Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the risk of death from prostate cancer in half.
Scientists at NYULangoneHealth examined cancerous and benign tissues from 10 patients with prostate cancer, the most common cancer among American men ... The prevalence of prostate cancer is only ...
Prostate cancer remains a significant global health burden, representing the most common cancer diagnosis in men and the second leading cause of cancer-related mortality in men behind lung cancer.1 ...
Focal therapy, a non-invasive treatment which targets cancerous cells while avoiding damaging surrounding tissue, was introduced to the UK in 2006. ....
While experts stress the findings are early and do not prove cause and effect, they add to growing concern about how widespread plastic exposure may affect the body over time ....